ethyl 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylate, 95.0%, 500mg

2-Fluoromandelic acid, 97.0%, 25g

(S)-3-Chloro-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride, 97%, 250mg

(S)-2-(tert-Butoxycarbonyl)-2-azaspiro[4.4]nonane-3-carboxylic acid, 97%, 100mg

6-Amino-5-nitropyrimidine-2,4(1H,3H)-dione, 97.0%, 250mg

Ethyl 2-acetylheptanoate, 95.0%, 500g

4-Pyridylacetonitrile hydrochloride, 95.0%, 10g

2,6-Bis((3aS,8aR)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)pyridine, 95.0%, 1g

BIS(TRIMETHYLSILYL) SULFIDE, 95%, 25g

Flat flange reaction vial, cylindrical, graduated, with tempering jacket GL connecting piece, DN 100, 500 ml, 130 mm, 1 Piece

7-Bromo-5-methoxy-1-benzofuran, 95+%, 250mg

Benzyl 4-({[3-(methoxycarbonyl)phenyl]amino}carbonyl)piperidine-1-carboxylate, 250mg

Sodium selenite, min. 99%, pa, 500 g, plastic packaging.